Healthcare & Life Sciences
Transcend Therapeutics
United Stateswww.transcendtherapeutics.com/
acquiredacquired
acquired
Stage
1
Investors
About
Transcend Therapeutics develops rapid-acting neuroplastic drugs aimed at treating neuropsychiatric diseases such as PTSD, focusing on options where existing psychiatric medications have limited efficacy.
Explore Transcend Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.